According to Gram Research analysis of 111 published cases, primary intestinal lymphangiectasia affects adults about as often as children, with 52.3% of patients being adults. However, adults typically wait 4 years for diagnosis compared to 2.2 years for children, and one-third of adults experience delays of at least 10 years. This rare condition damages the intestinal lymphatic system, causing protein loss and nutritional problems, but is often overlooked in adult patients.
A rare condition called primary intestinal lymphangiectasia (PIL) has long been thought of as a childhood disease, but new research shows it affects adults just as often. Gram Research analysis of 111 individual cases found that about half of PIL patients are actually adults, though doctors often take much longer to diagnose them. The condition damages the lymphatic system in the intestines, causing protein loss and nutritional problems. This study highlights that adults with PIL often wait years for a correct diagnosis, and doctors need better tools to identify and track this condition in both children and adults.
Key Statistics
A 2026 systematic review of 111 primary intestinal lymphangiectasia cases found that 52.3% of patients were adults, challenging the traditional view that this condition only affects children.
Adults with primary intestinal lymphangiectasia experienced a median diagnostic delay of 4 years compared to 2.2 years in children, with one-third of adults waiting at least 10 years for diagnosis according to the 2026 Scandinavian Journal of Gastroenterology review.
Among 128 primary intestinal lymphangiectasia cases reviewed in 2026, only 28.9% had documented protein-losing enteropathy testing and 15.6% had immune system testing, indicating incomplete diagnostic confirmation across the medical literature.
A 2026 analysis of 93 primary intestinal lymphangiectasia patients found baseline albumin levels averaged 1.90 g/dL, indicating severe protein loss characteristic of this rare intestinal lymphatic disorder.
The Quick Take
- What they studied: How often primary intestinal lymphangiectasia occurs in adults versus children, how long it takes to diagnose, and what immune system changes happen in each group.
- Who participated: 111 individual patients with primary intestinal lymphangiectasia whose cases were reported in medical literature, plus two additional groups of pediatric patients (28 and 34 children) reported together. About half were adults and half were children.
- Key finding: Adults made up 52.3% of PIL cases, but doctors took an average of 4 years to diagnose them compared to 2.2 years for children. One-third of adults waited at least 10 years for a diagnosis.
- What it means for you: If you have unexplained protein loss, severe diarrhea, or swelling that doctors can’t explain, PIL might be worth investigating. Adults should be aware this condition exists in their age group, and doctors need to consider it more often when diagnosing digestive problems.
The Research Details
Researchers searched six major medical databases for all published reports about primary intestinal lymphangiectasia from the beginning of medical records through January 2026. They carefully reviewed each report and pulled out information about individual patients, including their age at diagnosis, how long it took to diagnose them, and what tests doctors used. They compared the adult patients to pediatric patients using statistical tests to see if there were meaningful differences between the groups.
The study included 111 patients with clear age information at diagnosis, plus two additional groups of children (28 and 34 patients) that were reported together rather than individually. The researchers looked at diagnostic delays, protein levels in the blood, immune system testing, and treatment approaches. They compared adults and children using standard statistical methods to determine if differences were real or just due to chance.
This research approach is important because PIL is so rare that no single hospital or doctor sees many cases. By gathering all published cases from around the world, researchers can spot patterns that wouldn’t be visible from one clinic’s experience. This helps doctors understand how common adult PIL really is and how it differs from childhood PIL. The systematic review also reveals gaps in how PIL is currently diagnosed and tracked, which can guide improvements in medical practice.
This study has some important limitations to understand. The researchers relied on cases that were published in medical journals, which means they may have missed cases that doctors didn’t report or publish. Published cases often represent unusual or interesting situations, so they may not reflect typical PIL patients. Additionally, the information available in published reports was incomplete: only 28.9% of cases had documented protein-losing enteropathy testing (the main test for PIL), and only 15.6% had immune system testing. This incomplete reporting makes it harder to draw firm conclusions about how PIL presents in adults versus children.
What the Results Show
Among 111 patients with known ages at diagnosis, 58 (52.3%) were adults and 53 (47.7%) were children. This finding challenges the common belief that PIL is purely a pediatric disease. Adults experienced a median diagnostic delay of 4 years (ranging from 1 to 15 years), while children experienced a median delay of 2.2 years (ranging from 0.7 to 6.6 years). Although this difference wasn’t statistically significant, a more striking pattern emerged when looking at extreme delays: one-third of adults (33.3%) waited at least 10 years for diagnosis, compared to only 10% of children.
When researchers measured albumin (a key protein that leaks out in PIL), the average level was 1.90 g/dL, which is very low and indicates significant protein loss. This low protein level was consistent across both age groups. However, the study found that doctors documented protein-losing enteropathy testing (the main diagnostic test for PIL) in only 37 of 128 cases (28.9%), and immune system testing in only 20 cases (15.6%). This incomplete testing suggests that PIL diagnosis may be missed or delayed because doctors aren’t consistently using the right tests.
Treatment patterns showed that diet modifications and medium-chain triglycerides (a special type of fat that’s easier to absorb) were the most common approaches used. However, the study found no significant differences in treatment effectiveness or recurrence rates between adults and children, partly because follow-up information was incomplete. Only 62.5% of cases included information about how long patients were followed after diagnosis. The researchers noted that many published cases lacked standardized follow-up data, making it impossible to determine which treatments work best or how often PIL returns after treatment.
This research confirms what some recent studies have suggested: PIL is not exclusively a childhood disease. Previous medical textbooks and older literature typically described PIL as a pediatric condition, but this systematic review shows that adults represent nearly half of all reported PIL cases. The finding that adults experience longer diagnostic delays aligns with other rare disease research showing that conditions considered ‘pediatric’ are often overlooked in adult patients. The incomplete diagnostic testing documented in this study reflects a broader problem in PIL care: there is no standardized diagnostic protocol, so different doctors use different tests and approaches.
The most significant limitation is that this study relied on published case reports and small cohorts, which represent a biased sample of all PIL patients. Cases that are unusual, severe, or successfully treated are more likely to be published than routine cases. This means the true frequency of PIL in adults may be different from what the published literature suggests. Additionally, the incomplete reporting of diagnostic tests, immune findings, and follow-up data means researchers couldn’t fully compare adults and children on many important measures. The study also couldn’t determine treatment effectiveness or recurrence rates because follow-up information was missing in many cases. Finally, the study couldn’t identify secondary causes of lymphangiectasia (cases caused by other diseases) in all patients, which means some cases may have been misclassified.
The Bottom Line
If you have chronic diarrhea, protein loss, swelling, or nutritional deficiencies that haven’t been explained by standard testing, ask your doctor to consider PIL. Adults should be aware that this condition can develop at any age. Doctors should use standardized diagnostic testing including protein-losing enteropathy confirmation and immune system evaluation. Treatment typically starts with dietary changes and medium-chain triglycerides, which are easier to absorb than regular fats. These recommendations are based on current practice patterns, though the evidence base is limited due to PIL’s rarity.
Adults with unexplained chronic diarrhea, low blood protein levels, or nutritional deficiencies should discuss PIL with their gastroenterologist. Parents of children with similar symptoms should also ensure PIL is considered. Gastroenterologists and primary care doctors should be aware that PIL occurs in adults more often than traditionally taught. This research is less relevant for people without digestive symptoms or those with known secondary causes of lymphangiectasia (such as cancer or heart disease).
Diagnostic delays averaged 4 years in adults, so patience is important. Once diagnosed, dietary treatment can begin immediately, though it may take weeks to months to see improvements in symptoms and protein levels. Long-term management requires ongoing monitoring, but the study found insufficient data on typical recovery timelines. Individual outcomes vary significantly based on disease severity and treatment response.
Frequently Asked Questions
Can adults get primary intestinal lymphangiectasia or is it only a childhood disease?
Adults develop primary intestinal lymphangiectasia regularly. A 2026 review found that 52.3% of reported cases occurred in adults, though doctors often miss or delay diagnosis by an average of 4 years compared to 2.2 years in children.
What are the main symptoms of primary intestinal lymphangiectasia in adults?
Adults typically experience chronic diarrhea, severe protein loss causing low blood albumin levels, swelling in the legs and abdomen, and nutritional deficiencies. Symptoms result from damaged lymphatic vessels in the intestines leaking protein into the digestive tract.
How is primary intestinal lymphangiectasia diagnosed?
Diagnosis requires protein-losing enteropathy testing to confirm protein loss through the intestines, along with imaging studies and sometimes intestinal biopsy. However, a 2026 review found only 28.9% of published cases had documented protein-losing enteropathy testing, suggesting inconsistent diagnostic practices.
What treatments work best for primary intestinal lymphangiectasia?
Diet modifications and medium-chain triglycerides (easier-to-absorb fats) are the primary treatments. However, the 2026 review found no significant differences in treatment effectiveness between adults and children, partly due to incomplete follow-up data in published cases.
Why do adults wait so long to get diagnosed with primary intestinal lymphangiectasia?
Adults experience longer diagnostic delays because PIL is traditionally considered a pediatric disease, so doctors rarely consider it in adult patients. A 2026 review found one-third of adults waited at least 10 years for diagnosis, compared to 10% of children.
Want to Apply This Research?
- Track weekly albumin levels (if tested) and daily stool consistency using a 1-5 scale. Record dietary adherence to medium-chain triglyceride intake and note any swelling or weight changes. This creates a clear picture of how dietary changes affect your condition over time.
- Start a food diary documenting medium-chain triglyceride consumption and symptom severity. Set reminders for scheduled albumin blood tests. Log weekly weight and measure abdominal swelling to track protein loss trends. Share this data with your gastroenterologist at each visit.
- Establish a monthly review routine comparing albumin trends, stool patterns, and weight changes. Set quarterly goals for albumin improvement. Track which dietary modifications correlate with symptom improvement. Share compiled data with your medical team to guide treatment adjustments.
This article summarizes research about primary intestinal lymphangiectasia but is not medical advice. PIL is a rare condition requiring specialized medical evaluation and treatment. If you experience chronic diarrhea, unexplained protein loss, swelling, or nutritional deficiencies, consult a gastroenterologist for proper diagnosis. Do not attempt self-diagnosis or self-treatment based on this information. Treatment decisions should be made with your healthcare provider based on your individual medical history and test results.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.